TY - JOUR AU - Lavanchy, D. PY - 2004 DA - 2004// TI - Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures JO - J Viral Hepatitis VL - 11 UR - https://doi.org/10.1046/j.1365-2893.2003.00487.x DO - 10.1046/j.1365-2893.2003.00487.x ID - Lavanchy2004 ER - TY - JOUR AU - Mahoney, F. J. PY - 1999 DA - 1999// TI - Update on diagnosis, management, and prevention of hepatitis B virus infection JO - Clin Microbiol Rev VL - 12 ID - Mahoney1999 ER - TY - JOUR AU - Toy, M. PY - 2011 DA - 2011// TI - Age and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review JO - BMC Infect Dis VL - 11 UR - https://doi.org/10.1186/1471-2334-11-337 DO - 10.1186/1471-2334-11-337 ID - Toy2011 ER - TY - JOUR PY - 2012 DA - 2012// JO - J Hepatol VL - 57 UR - https://doi.org/10.1016/j.jhep.2012.02.010 DO - 10.1016/j.jhep.2012.02.010 ID - ref4 ER - TY - JOUR AU - Lok, A. S. F. AU - McMahon, B. J. PY - 2009 DA - 2009// TI - Chronic hepatitis B: update 2009 JO - Hepatology VL - 50 ID - Lok2009 ER - TY - JOUR AU - Liaw, Y. F. AU - Kao, J. H. AU - Piratvisuth, T. AU - Chan, H. L. Y. AU - Chien, R. N. AU - Liu, C. J. AU - Gane, E. AU - Locarnini, S. AU - Lim, S. G. AU - Han, K. H. AU - Amarapurkar, D. AU - Cooksley, G. AU - Jafri, W. AU - Mohamed, R. AU - Hou, J. L. AU - Chuang, W. L. AU - Lesmana, L. A. AU - Sollano, J. AU - Suh, D. J. AU - Omata, M. PY - 2012 DA - 2012// TI - Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update JO - Hepatol Int VL - 6 UR - https://doi.org/10.1007/s12072-012-9365-4 DO - 10.1007/s12072-012-9365-4 ID - Liaw2012 ER - TY - JOUR AU - Liaw, Y. F. AU - Gane, E. AU - Leung, N. AU - Zeuzem, S. AU - Wang, Y. AU - Lai, C. L. PY - 2009 DA - 2009// TI - 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B JO - Gastroenterology VL - 136 UR - https://doi.org/10.1053/j.gastro.2008.10.026 DO - 10.1053/j.gastro.2008.10.026 ID - Liaw2009 ER - TY - STD TI - Turkish Statistics Agency, Population Statics 2014. http://www.tuik.gov.tr/UstMenu.do?metod=temelist. Last updated 29.09.2015. UR - http://www.tuik.gov.tr/UstMenu.do?metod=temelist ID - ref8 ER - TY - JOUR AU - Yamazhan, T. AU - Kurtaran, B. AU - Pullukcu, H. AU - Yuksel, E. AU - Ozkaya, D. AU - Tasbakan, M. I. AU - Sipahi, O. R. AU - Durusoy, R. AU - Aksu, H. S. Z. PY - 2014 DA - 2014// TI - Pegylated interferon in HBeAg-positive and -negative chronic hepatitis B patients: posttreatment 1-year results of three Turkish centres JO - J Chemother VL - 26 UR - https://doi.org/10.1179/1973947813Y.0000000152 DO - 10.1179/1973947813Y.0000000152 ID - Yamazhan2014 ER - TY - STD TI - Health Application Notification (SUT). Link http://mevzuat.basbakanlik.gov.tr/Metin.Aspx?MevzuatKod=9.5.17229&MevzuatIliski=0&sourceXmlSearch=saC49FlC4B1k20. (Last: Updated: 16.10.2014). UR - http://mevzuat.basbakanlik.gov.tr/Metin.Aspx?MevzuatKod=9.5.17229&MevzuatIliski=0&sourceXmlSearch=saC49FlC4B1k20 ID - ref10 ER - TY - JOUR AU - Marcellin, P. AU - Gane, E. PY - 2014 DA - 2014// TI - Long term treatment with tenofovir disoproxil fumarate for chronic hepatitis b infection is safe and well tolerated and associated with durable virologic response with no detectable resistance: 8 year results from two phase 3 trials [AASLD abstract 229] JO - Hepatology VL - 60 ID - Marcellin2014 ER - TY - JOUR AU - Marcellin, P. AU - Gane, E. AU - Buti, M. PY - 2013 DA - 2013// TI - Regression of cirrhosis during treatment with Tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61425-1 DO - 10.1016/S0140-6736(12)61425-1 ID - Marcellin2013 ER - TY - JOUR AU - Kanwal, F. AU - Gralnek, I. A. AU - Martin, P. AU - Dulai, G. S. AU - Farid, M. AU - Spiegel, B. M. R. PY - 2005 DA - 2005// TI - Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis JO - Ann Intern Med VL - 142 UR - https://doi.org/10.7326/0003-4819-142-10-200505170-00007 DO - 10.7326/0003-4819-142-10-200505170-00007 ID - Kanwal2005 ER - TY - JOUR AU - Tenney, D. J. AU - Rose, R. E. AU - Baldick, C. J. AU - Pokornowski, K. A. AU - Eggers, B. J. AU - Fang, J. AU - Wichroski, M. J. AU - Xu, D. AU - Yang, J. AU - Wilber, R. B. AU - Colonno, R. J. PY - 2009 DA - 2009// TI - Long-term monitoring shows hepatitis B virus resistance to Entecavir in nucleoside-naïve patients is rare through 5 years of therapy JO - Hepatology VL - 49 UR - https://doi.org/10.1002/hep.22841 DO - 10.1002/hep.22841 ID - Tenney2009 ER - TY - JOUR AU - Chae, H. B. AU - Hann, H. W. PY - 2007 DA - 2007// TI - Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with Lamivudine JO - World J Gastroenterol VL - 13 UR - https://doi.org/10.3748/wjg.v13.i30.4085 DO - 10.3748/wjg.v13.i30.4085 ID - Chae2007 ER - TY - STD TI - Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, Chutaputti A, Rasenack J, Hou J, O’Brien C, Nguyen TT, Jia J, Poynard T, Belanger B, Bao W, Naoumov NV. Baseline characteristics and early on-treatment response predict the outcomes of 2 years of Telbivudinee treatment of chronic hepatitis B. 2009;51(1):11–20. ID - ref16 ER - TY - STD TI - Marcellin P, Heathcote EJ, Buti M, Gane E, Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Iskren Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008;359:2442–55. ID - ref17 ER - TY - JOUR AU - Arnold, E. AU - Yuan, Y. AU - Iloeje, U. AU - Cook, G. PY - 2008 DA - 2008// TI - Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B JO - Appl Health Econ Health Policy. VL - 6 UR - https://doi.org/10.1007/BF03256136 DO - 10.1007/BF03256136 ID - Arnold2008 ER - TY - STD TI - Yuan Y, Iloeje UH, Hay J, ve Saab S. Evaluation of the Cost-Effectiveness of Entecavir Versus Lamivudine in Hepatitis BeAg-Positive Chronic Hepatitis B Patients. J Manag Care Pharm. 2008;14(1):21–33. ID - ref19 ER - TY - JOUR AU - Lai, C. L. AU - Gane, E. AU - Liaw, Y. F. AU - Hsu, C. W. AU - Thongsawat, S. AU - Wang, Y. AU - Chen, Y. AU - Heathcote, E. J. AU - Rasenack, J. AU - Bzowej, N. AU - Naoumov, N. V. AU - Di, B. i. s. c. e. g. l. i. e. A. M. AU - Zeuzem, S. AU - Moon, Y. M. AU - Goodman, Z. AU - Chao, G. AU - Constance, B. F. AU - Brown, N. A. PY - 2007 DA - 2007// TI - Telbivudine versus lamivudine in patients with chronic hepatitis B JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa066422 DO - 10.1056/NEJMoa066422 ID - Lai2007 ER - TY - BOOK AU - Tatar, M. AU - ve, A. I. PY - 2010 DA - 2010// TI - Sağlık Teknolojilerinin Değerlendirilmesi—İlaç Geri Ödeme Kararları İçin Bir Model Önerisi PB - Nobel Basım Yayın CY - Ankara ID - Tatar2010 ER - TY - STD TI - Malhan S, Oksuz E, Eminsoy G, Sözen F, Ünsal A, Ersoy K.“Kronik Hepatit B ve Komplikasyonlarının Geri Ödeme Kurumu Perspektifinden Türkiye’ye Maliyeti” The Turkish J Gastroentrology 2009; 20(1):207. ID - ref22 ER - TY - JOUR AU - Iloeje, U. H. AU - Yang, H. I. AU - Su, J. AU - Jen, C. L. AU - You, S. L. AU - Chen, C. J. PY - 2006 DA - 2006// TI - Predicting cirrhosis risk based on the level of circulating hepatitis B viral load JO - Gastroenterology. VL - 130 UR - https://doi.org/10.1053/j.gastro.2005.11.016 DO - 10.1053/j.gastro.2005.11.016 ID - Iloeje2006 ER - TY - JOUR AU - Orlewska, E. AU - Zammit, D. AU - Yuan, Y. AU - Kutikova, L. AU - Berak, H. AU - Halota, W. AU - ve Hay, J. W. PY - 2008 DA - 2008// TI - The cost effectiveness analysis Entecavir in the treatment chronic hepatitis B (CHB) patients in Poland JO - Hepatology VL - 4 ID - Orlewska2008 ER - TY - JOUR AU - Chen, C. J. AU - Yang, H. I. AU - Su, J. AU - Jen, C. L. AU - You, S. L. AU - Lu, S. N. AU - Huang, G. T. AU - Iloeje, U. H. PY - 2006 DA - 2006// TI - Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.1.65 DO - 10.1001/jama.295.1.65 ID - Chen2006 ER - TY - STD TI - TUIK Life Expectacy on Birth. Link http://www.tuik.gov.tr/UstMenu.do?metod=temelist. Last Updated 16.08.2014. UR - http://www.tuik.gov.tr/UstMenu.do?metod=temelist ID - ref26 ER - TY - JOUR AU - Koçkaya, G. AU - Wertheimer, A. AU - Daylan Kockaya, P. AU - Esen, A. PY - 2009 DA - 2009// TI - Considering the cost-effectiveness of statins in family practice in Turkey from a payer perspective JO - Health VL - 1 UR - https://doi.org/10.4236/health.2009.14044 DO - 10.4236/health.2009.14044 ID - Koçkaya2009 ER - TY - STD TI - Hamby DM. A comparison of sensitivity analysis techniques Oregon State University. Link http://web.engr.oregonstate.edu/~hambydm/papers/senscomparison.pdf. Last updated 21.10.2015. UR - http://web.engr.oregonstate.edu/%7ehambydm/papers/senscomparison.pdf ID - ref28 ER - TY - JOUR AU - Veenstra, D. L. AU - Sullivan, S. D. AU - Lai, M. Y. AU - Lee, C. M. AU - Tsai, C. M. AU - Patel, K. K. PY - 2008 DA - 2008// TI - HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2007.00221.x DO - 10.1111/j.1524-4733.2007.00221.x ID - Veenstra2008 ER - TY - JOUR AU - Tu, A. H. T. AU - Woerdenbag, H. J. AU - Riewpaiboon, A. AU - Kane, S. AU - Le, D. M. AU - Postma, M. J. AU - Li, S. C. PY - 2012 DA - 2012// TI - Cost of illness of chronic hepatitis B infection in Vietnam JO - Value Health Reg Isssues VL - 1 UR - https://doi.org/10.1016/j.vhri.2012.03.008 DO - 10.1016/j.vhri.2012.03.008 ID - Tu2012 ER - TY - JOUR AU - Lu, J. AU - Xu, A. AU - Wang, J. AU - Zhang, L. AU - Song, L. AU - Li, R. AU - Zhang, S. AU - Zhuang, G. AU - Lu, M. PY - 2013 DA - 2013// TI - Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China JO - BMC Health Serv Res VL - 13 UR - https://doi.org/10.1186/1472-6963-13-37 DO - 10.1186/1472-6963-13-37 ID - Lu2013 ER - TY - JOUR AU - Owusu-Edusei, K. AU - Chesson, H. W. AU - Gift, T. L. AU - Tao, G. AU - Mahajan, R. AU - Ocfemia, M. C. AU - Kent, C. K. PY - 2013 DA - 2013// TI - The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008 JO - Sex Transm Dis VL - 40 UR - https://doi.org/10.1097/OLQ.0b013e318285c6d2 DO - 10.1097/OLQ.0b013e318285c6d2 ID - Owusu-Edusei2013 ER - TY - JOUR AU - Wong, W. W. L. AU - Woo, G. AU - Heathcote, E. J. AU - Krahn, M. PY - 2013 DA - 2013// TI - Disease burden of chronic hepatitis B among immigrants in Canada JO - Can J Gastroenterol VL - 27 ID - Wong2013 ER - TY - JOUR AU - Karahasanoğlu, F. B. AU - Asan, A. AU - Sacar, S. AU - Turgut, H. PY - 2013 DA - 2013// TI - Costs of treatment, follow-up, and complications of chronic hepatitis B and hepatitis C infections JO - Balkan Med J VL - 30 UR - https://doi.org/10.5152/balkanmedj.2013.7547 DO - 10.5152/balkanmedj.2013.7547 ID - Karahasanoğlu2013 ER - TY - JOUR AU - Lui, Y. Y. N. AU - Tsoi, K. K. F. AU - Wong, V. W. S. AU - Kao, J. H. AU - Hou, J. L. AU - Teo, E. K. AU - Mohamed, R. AU - Piratvisuth, T. AU - Han, K. H. AU - Mihm, U. AU - Wong, G. L. H. AU - Chan, H. L. Y. PY - 2010 DA - 2010// TI - Cost-effectiveness analysis of roadmap models in chronic hepatitis B using Tenofovir as the rescue therapy JO - Antiviral Therapy VL - 15 UR - https://doi.org/10.3851/IMP1496 DO - 10.3851/IMP1496 ID - Lui2010 ER - TY - JOUR AU - Buti, M. AU - Brosa, M. AU - Casado, M. A. AU - Rueda, M. AU - Esteban, R. PY - 2009 DA - 2009// TI - Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B JO - J Hepatol VL - 51 UR - https://doi.org/10.1016/j.jhep.2009.04.013 DO - 10.1016/j.jhep.2009.04.013 ID - Buti2009 ER -